Health
Biotech Company Closes After Funding Failure
Caribou Biosciences, a biotech company co-founded by Jennifer Doudna, is shutting down due to insufficient funding for its clinical trial. The closure highlights challenges in late-stage biotech development.
Coverage timeline — 2 articles
STAT News
Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.
2026-10-07 08:30 UTC
STAT News
Exon-skipping drugs present a critical test for the FDA’s goal of encouraging treatments for rare disease.
2026-10-07 08:30 UTC